PubRank

P Libby

Author PubWeight™ 318.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998 7.46
2 Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994 7.25
3 PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 1989 6.26
4 Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995 5.09
5 Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000 4.79
6 Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 1987 3.61
7 Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001 3.47
8 Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 1986 3.35
9 Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998 3.31
10 Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998 3.17
11 Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998 3.04
12 An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993 2.77
13 The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001 2.75
14 Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999 2.73
15 Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001 2.63
16 Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998 2.63
17 Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 1997 2.56
18 Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995 2.54
19 Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001 2.53
20 Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000 2.50
21 Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994 2.46
22 Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 1998 2.39
23 Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol 1989 2.39
24 Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999 2.33
25 Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol 1998 2.30
26 Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest 1973 2.28
27 Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest 1986 2.21
28 Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992 2.19
29 Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol 1972 2.19
30 Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999 2.16
31 Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999 2.13
32 Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997 2.12
33 Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995 2.11
34 Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998 2.11
35 Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972 2.10
36 An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001 2.09
37 PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 1999 2.07
38 The unstable atheroma. Arterioscler Thromb Vasc Biol 1997 2.05
39 Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991 2.04
40 Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol 1983 2.03
41 Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999 2.03
42 PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 1999 2.02
43 Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 1999 2.00
44 Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 1995 2.00
45 Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999 1.97
46 CD40 signaling and plaque instability. Circ Res 2001 1.97
47 Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001 1.96
48 Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles. Science 1978 1.93
49 Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999 1.86
50 Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest 1972 1.86
51 Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991 1.82
52 Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000 1.81
53 Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J Immunol 1987 1.79
54 Inflammation and thrombosis: the clot thickens. Circulation 2001 1.79
55 Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997 1.77
56 Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest 1998 1.76
57 Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation 1999 1.74
58 Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol 1996 1.71
59 Novel inflammatory markers of coronary risk: theory versus practice. Circulation 1999 1.65
60 Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk? J Cardiovasc Risk 2001 1.65
61 Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol 1997 1.65
62 Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986 1.64
63 Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci U S A 2000 1.63
64 Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J Exp Med 1987 1.61
65 The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res 2000 1.60
66 Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 1993 1.58
67 Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 1999 1.57
68 Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991 1.57
69 HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 2000 1.56
70 Implantation of vascular grafts lined with genetically modified endothelial cells. Science 1989 1.54
71 Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990 1.54
72 Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ Res 1997 1.54
73 Soluble CD40L and cardiovascular risk in women. Circulation 2001 1.52
74 Endothelial function and coronary artery disease. Curr Opin Lipidol 2001 1.52
75 Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003 1.51
76 The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med 2000 1.50
77 Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation 1972 1.50
78 Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 2000 1.49
79 Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997 1.48
80 Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 2001 1.47
81 Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995 1.46
82 Effects of intraaortic balloon counterpulsation on the severity of myocardial ischemic injury following acute coronary occlusion. Counterpulsation and myocardial injury. Circulation 1972 1.46
83 Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 1997 1.46
84 Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 1990 1.42
85 Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 1996 1.41
86 Degradation of the acetylcholine receptor in cultured muscle cells: selective inhibitors and the fate of undegraded receptors. Cell 1980 1.41
87 Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 2001 1.40
88 A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J Clin Invest 1986 1.39
89 The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994 1.39
90 Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med 1977 1.38
91 Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993 1.36
92 CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol 1999 1.33
93 CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 1998 1.32
94 Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998 1.32
95 Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem 2001 1.29
96 Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 1998 1.29
97 Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000 1.25
98 Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000 1.24
99 Regulation of major histocompatibility gene expression in human vascular smooth muscle cells. Arteriosclerosis 1989 1.24
100 Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995 1.23
101 The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 1997 1.23
102 Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects of ventricular function in the normal and ischaemic heart. Cardiovasc Res 1973 1.21
103 Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1995 1.20
104 Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 1993 1.20
105 Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am J Pathol 1991 1.19
106 Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci U S A 1992 1.19
107 PPARalpha activators inhibit tissue factor expression and activity in human monocytes. Circulation 2001 1.18
108 CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 2000 1.18
109 Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995 1.17
110 Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest 1993 1.16
111 Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med 1999 1.16
112 Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 1999 1.15
113 Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J Clin Invest 1989 1.15
114 Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res 1998 1.12
115 Inflammation and atherothrombosis. Ann N Y Acad Sci 2001 1.12
116 Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. Cell Immunol 1989 1.12
117 Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 1996 1.12
118 Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997 1.12
119 Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001 1.11
120 Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol 1998 1.10
121 Effect of pharmacologic agents on the function of the ischemic heart. Am J Cardiol 1973 1.10
122 Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. J Nutr 1992 1.10
123 Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 1996 1.09
124 Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998 1.09
125 Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997 1.09
126 Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. J Immunol 1995 1.08
127 Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur J Cell Biol 1998 1.08
128 The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol 1998 1.07
129 Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol 1999 1.06
130 Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995 1.06
131 Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993 1.04
132 T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am J Pathol 1999 1.03
133 Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res 1996 1.02
134 Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. J Immunol 1997 1.02
135 Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol 1999 1.01
136 Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 1994 1.01
137 Small mechanical strains selectively suppress matrix metalloproteinase-1 expression by human vascular smooth muscle cells. J Biol Chem 1998 1.01
138 Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992 1.00
139 Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler Thromb Vasc Biol 1995 1.00
140 Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction. J Am Coll Cardiol 1999 1.00
141 Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. Circ Res 2000 1.00
142 The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation 1975 0.99
143 IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. J Immunol 1988 0.99
144 Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp Cell Res 1992 0.99
145 Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 1999 0.98
146 Reduction of infarct size following coronary occlusion. Circ Res 1974 0.98
147 Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients. Ann Intern Med 1975 0.98
148 Matrix matters. Circulation 2000 0.98
149 Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost 2014 0.97
150 Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells. Arteriosclerosis 1985 0.97
151 Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol 1998 0.96
152 CD154 (CD40 ligand). Int J Biochem Cell Biol 2000 0.96
153 Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot Essent Fatty Acids 1995 0.96
154 Reduction of protein degradation and atrophy in cultured fetal mouse hearts by leupeptin. Am J Physiol 1979 0.96
155 Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol 1994 0.96
156 Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo. Thromb Haemost 2011 0.95
157 Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. Am J Pathol 2000 0.95
158 The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc Med 1998 0.95
159 Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 1998 0.95
160 Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J Biol Chem 1996 0.94
161 Long-term culture of contractile mammalian heart cells in a defined serum-free medium that limits non-muscle cell proliferation. J Mol Cell Cardiol 1984 0.94
162 Ligation of CD40 activates interleukin 1beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1beta. J Biol Chem 1997 0.94
163 Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle. Biochem J 1980 0.93
164 Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry. Am J Pathol 1998 0.92
165 Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells. J Lipid Res 1995 0.90
166 MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arterioscler Thromb Vasc Biol 1999 0.90
167 Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol 1997 0.90
168 The effect of glucose-insulin-potassium on cardiac ultrastructure following acute experimental coronary occlusion. Am J Pathol 1973 0.89
169 Biomechanical strain induces class a scavenger receptor expression in human monocyte/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension. Circulation 2001 0.89
170 Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation 1995 0.87
171 The inhibition of endothelial activation by unsaturated fatty acids. Lipids 1999 0.86
172 Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996 0.86
173 Comparison of the control and pathways for degradation of the acetylcholine receptor and average protein in cultured muscle cells. J Cell Physiol 1981 0.86
174 Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol 1985 0.86
175 Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth. Lab Invest 1992 0.86
176 Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. Lymphokine Res 1989 0.85
177 Induction of DNA synthesis by a single transient mechanical stimulus of human vascular smooth muscle cells. Role of fibroblast growth factor-2. Circulation 1996 0.85
178 The role of protein breakdown in growth, quiescence, and starvation of vascular smooth muscle cells. J Cell Physiol 1984 0.85
179 Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998 0.84
180 Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy. J Immunol 1989 0.83
181 Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: production of a platelet-derived growth factor-like mitogen and expression of a gene for a platelet-derived growth factor receptor--a preliminary study. J Vasc Surg 1989 0.83
182 Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts. Circulation 2001 0.83
183 Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 2001 0.83
184 Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix. Circ Res 2001 0.82
185 Morphological changes in cultured myotubes treated with agents that interfere with lysosomal function. Cell Tissue Res 1981 0.82
186 Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. Arterioscler Thromb 1994 0.82
187 Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation 1997 0.81
188 Ligation of CD40 onvascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activity. Ann N Y Acad Sci 2001 0.81
189 Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis, and Chlamydia infection. J Infect Dis 2000 0.81
190 Restenosis revisited--new targets, new therapies. N Engl J Med 1997 0.81
191 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors. J Am Coll Cardiol 1996 0.80
192 Mesenchymal target cell specificity of egg granuloma-derived fibroblast growth factor in schistosomiasis. J Infect Dis 1987 0.80
193 Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis. Am J Med 1996 0.80
194 An assessment of the contribution of chest radiography in outpatients with acute chest complaints: a prospective study. Radiology 1981 0.80
195 Plaque instability--the real challenge for atherosclerosis research in the next decade? Cardiovasc Res 1999 0.79
196 Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 1995 0.79
197 Gene therapy of restenosis: promise and perils. Circ Res 1998 0.78
198 Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A. Transplant Proc 1995 0.78
199 Systemic thrombin inhibition by Hirulog does not alter medial smooth muscle cell proliferation and inflammatory activation after vascular injury in the rabbit. Cardiovasc Drugs Ther 1999 0.78
200 Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplantation antigens. J Thorac Cardiovasc Surg 1993 0.78
201 Atheroma: more than mush. Lancet 1996 0.78
202 Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease? J Heart Lung Transplant 1996 0.78
203 Matrix metalloproteinases: not-so-innocent bystanders in heart failure. J Clin Invest 2000 0.78
204 Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points. Curr Opin Lipidol 1996 0.77
205 Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med 2011 0.77
206 Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: the role of contaminant platelet-derived growth factor. J Cell Physiol 1985 0.77
207 The active roles of cells of the blood vessel wall in health and disease. Mol Aspects Med 1987 0.77
208 Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts: a possible relationship with graft coronary arteriosclerosis. Transplantation 1999 0.76
209 Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice. Atherosclerosis 2000 0.76
210 Elaboration by mammalian mesenchymal cells infected with Trypanosoma cruzi of a fibroblast-stimulating factor that may contribute to chagasic cardiomyopathy. Infect Immun 1987 0.76
211 Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma. Ann N Y Acad Sci 2000 0.76
212 Adult human endothelial cell coverage of small-caliber Dacron and polytetrafluoroethylene vascular prostheses in vitro. J Surg Res 1986 0.76
213 Molecular mediators of arterial inflammation: a role for microbial products? Am Heart J 1999 0.76
214 Regulation of protein degradation in skeletal muscle. Biochem Soc Trans 1980 0.76
215 Cytokines score a knockout. Harnessing gene targeting to gain insight into the pathogenesis of myocarditis. Circulation 1997 0.75
216 Vascular cells have limited capacities to activate and differentiate T cells: implications for transplant vascular sclerosis. Transpl Immunol 1997 0.75
217 Endothelial cell seeding of small-caliber synthetic grafts in the baboon. Surgery 1986 0.75
218 How our growing understanding of inflammation has reshaped the way we think of disease and drug development. Clin Pharmacol Ther 2010 0.75
219 Atheromas that cause fatal thrombosis are usually large and frequently accompanied by vessel enlargement. Cardiovasc Pathol 2001 0.75
220 Endothelial activation potentiates neointimal lesion formation in the rabbit aorta after balloon injury. Ann N Y Acad Sci 1997 0.75
221 Report on student participation in organized medicine. Calif Med 1971 0.75
222 Nontraditional coronary risk factors and vascular biology: the frontiers of preventive cardiology. J Investig Med 1998 0.75
223 Towards an understanding of the molecular pathogenesis of acute coronary syndromes. Cardiologia 1997 0.75
224 Genetically modified endothelial cells in the treatment of human diseases. Trans Assoc Am Physicians 1989 0.75
225 Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts. Transplant Proc 1999 0.75
226 Effect of polycyclic hydrocarbons on steroid 11 beta-hydroxylase activity of the adrenal in rats. Cancer Res 1968 0.75
227 A second term for the editors. Status and goals for the review process. Circ Res 1996 0.75
228 Interrelation between atherosclerosis and restenosis. Z Kardiol 1995 0.75
229 Cellular and molecular biology of the cardiovascular system. Circ Res 1992 0.75
230 Activation of smooth muscle and endothelial cells following balloon injury. Ann N Y Acad Sci 1995 0.75
231 The direct effect of injectable cyclosporine and its vehicle, cremophor, on endothelial vascular cell adhesion molecule-1 expression. Ricinoleic acid inhibits coronary artery endothelial activation. Transplantation 1995 0.75
232 Inducible gene expression in vascular wall cells and lesional leukocytes. J Vasc Surg 1992 0.75
233 The functions of blood vessel wall cells in atherogenesis and coronary artery disease. Arq Bras Cardiol 1989 0.75